Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial.

Auteurs : Aalders KC, Kuijer A, Straver ME, Slaets L, Litiere S, Viale G, Vant Veer LJ, Glas AM, Delorenzi M, van Dalen T, Tryfonidis K, Piccart-Gebhart M, Cardoso F, Rutgers EJ
Jaar : 2017
Journal : Eur J Cancer
Volume : 79
Pagina's : 98-105

Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations.

Auteurs : Brown D, Smeets D, Székely B, Larsimont D, Szász AM, Adnet PY, Rothé F, Rouas G, Nagy ZI, Faragó Z, Dank M, Szentmártoni G, Udvarhelyi N, Zoppoli G, Pusztai L, Piccart-Gebhart M, Kulka J, Lambrechts D, Sotiriou C, Desmedt C
Jaar : 2017
Journal : Nat Commun
Volume : 8
Pagina's : 14944

ESMO-Magnitude of Clinical Benefit Scale version 1.1.

Auteurs : Cherny NI, Dafni U, Bogaerts J, Latino NJ, Pentheroudakis G, Douillard JY, Tabernero J, Zielinski C, Piccart-Gebhart M, de Vries EGE
Jaar : 2017
Journal : Ann Oncol
Volume : 28
Pagina's : 2340-2366

HER2-positive breast cancer is lost in translation: time for patient-centered research.

Auteurs : Gingras I, Gebhart G, de Azambuja E, Piccart-Gebhart M
Jaar : 2017
Journal : Nat Rev Clin Oncol
Volume : 14(11)
Pagina's : 669-681

Reply to the letter to the editor 'Addressing the quality of the ESMO-MCBS' by Del Paggio.

Auteurs : Cherny NI, Dafni U, Bogaerts J, Pentheroudakis G, Tabernero J, Zielinski C, Piccart-Gebhart M, de Vries EGE
Jaar : 2017
Journal : Ann Oncol
Volume : 28
Pagina's : 2031-2032

The AURORA pilot study for molecular screening of patients with advanced breast cancer-a study of the breast international group.

Auteurs : Maetens M, Brown D, Irrthum A, Aftimos P, Viale G, Loibl S, Laes JF, Campbell PJ, Thompson A, Cortes J, Seiler S, Vinnicombe S, Oliveira M, Rothé F, Bareche Y, Fumagalli D, Zardavas D, Desmedt C, Piccart-Gebhart M, Loi S, Sotiriou C
Jaar : 2017
Journal : NPJ Breast Cancer
Volume : 3
Pagina's : 23

Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper.

Auteurs : Aapro M, Astier A, Audisio R, Banks I, Bedossa P, Brain E, Cameron D, Casali P, Chiti A, De Mattos-Arruda L, Kelly D, Lacombe D, Nilsson PJ, Piccart M, Poortmans P, Riklund K, Saeter G, Schrappe M, Soffietti R, Travado L, Van Poppel H, Wait S, Naredi P
Jaar : 2017
Journal : Eur J Cancer
Volume : 82
Pagina's : 193-202

Targeting immune checkpoints in breast cancer: an update of early results.

Auteurs : Solinas C, Gombos A, Latifyan S, Piccart-Gebhart M, Kok M, Buisseret L
Jaar : 2017
Journal : ESMO Open
Volume : 2
Pagina's : e000255

Cancer drugs, survival and ethics: a critical look from the inside.

Auteurs : Piccart-Gebhart M, Pondé N
Jaar : 2016
Journal : ESMO Open
Volume : 1
Pagina's : e000149

The European Cancer Patient's Bill of Rights, update and implementation 2016.

Auteurs : Højgaard L, Löwenberg B, Selby P, Lawler M, Banks I, Law K, Albreht T, Armand JP, Barbacid M, Barzach M, Bergh J, Cameron D, Conte P, de Braud F, de Gramont A, de Lorenzo F, Diehl V, Diler S, Erdem S, Geissler J, Gore-Booth J, Henning G, Horgan D, Jassem J, Johnson P, Kaasa S, Kapitein P, Karjalainen S, Kelly J, Kienesberger A, La Vecchia C, Lacombe D, Lindahl T, Luzzatto L, Malby R, Mastris K, Meunier F, Murphy M, Naredi P, Nurse P, Oliver K, Pearce J, Pelouchov J, Piccart-Gebhart M, Pinedo B, Spurrier-Bernard G, Sullivan R, Tabernero J, van de Velde C, van Herk B, Vedsted P, Waldmann A, Weller D, Wilking N, Wilson R, Yared W, Zielinski C, Zur Hausen H, Le Chevalier T, Johnston P
Jaar : 2016
Journal : ESMO Open
Volume : 1
Pagina's : e000127

Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.

Auteurs : Buisseret L, Garaud S, de Wind A, Van den Eynden G, Boisson A, Solinas C, Gu-Trantien C, Naveaux C, Lodewyckx JN, Duvillier H, Craciun L, Veys I, Larsimont D, Piccart-Gebhart M, Stagg J, Sotiriou C, Willard-Gallo K
Jaar : 2016
Journal : Oncoimmunology
Volume : 6
Pagina's : e1257452

70-Gene Signature in Early-Stage Breast Cancer.

Auteurs : van’t Veer LJ, Rutgers EJT, Piccart-Gebhart M
Jaar : 2016
Journal : N Engl J Med
Volume : 375
Pagina's : 2200-2201

Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.

Auteurs : Bottomley A, Pe M, Sloan J, Basch E, Bonnetain F, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Dueck AC, Devlin N, Flechtner HH, Gotay C, Greimel E, Griebsch I, Groenvold M, Hamel JF, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Moinpour CM, Musoro J, OConnor D, Oliver K, Piault-Louis E, Piccart-Gebhart M, Pimentel FL, Quinten C, Reijneveld JC, Schürmann C, Smith AW, Soltys KM, Taphoorn MJ, Velikova G, Coens C
Jaar : 2016
Journal : Lancet Oncol
Volume : 17
Pagina's : e510-e514

Targeted adjuvant therapy in breast cancer.

Auteurs : Zardavas D, Tryfonidis K, Goulioti T, Piccart-Gebhart M
Jaar : 2016
Journal : Expert Rev Anticancer Ther
Volume : 16(12)
Pagina's : 1263-75

Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.

Auteurs : Bense RD, Sotiriou C, Piccart-Gebhart M, Haanen JB, van Vugt MA, de Vries EG, Schröder CP, Fehrmann RS
Jaar : 2016
Journal : J Natl Cancer Inst
Volume : 109

Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers.

Auteurs : Fumagalli D, Wilson TR, Salgado R, Lu X, Yu J, OBrien C, Walter K, Huw LY, Criscitiello C, Laios I, Jose V, Brown DN, Rothé F, Maetens M, Zardavas D, Savas P, Larsimont D, Piccart-Gebhart M, Michiels S, Lackner MR, Sotiriou C, Loi S
Jaar : 2016
Journal : Ann Oncol
Volume : 27
Pagina's : 1860-6

Pathway level alterations rather than mutations in single genes predict response to HER2 targeted therapies in the neo-ALTTO trial.

Auteurs : Shi W, Jiang T, Nuciforo P, Hatzis C, Holmes E, Harbeck N, Sotiriou C, Peña L, Loi S, Rosa DD, Chia S, Wardley A, Ueno T, Rossari J, Eidtmann H, Armour A, Piccart-Gebhart M, Rimm DL, Baselga J, Pusztai L
Jaar : 2016
Journal : Ann Oncol
Volume : 28(1)
Pagina's : 128-35

Endocrine treatment in breast cancer: Cure, resistance and beyond.

Auteurs : Tryfonidis K, Zardavas D, Katzenellenbogen BS, Piccart-Gebhart M
Jaar : 2016
Journal : Cancer Treat Rev
Volume : 50
Pagina's : 68-81

Reply to the letter to the editor 'Utilisation of the ESMO-MCBS in practice of HTA' by Wild et al.

Auteurs : Cherny NI, Sullivan R, Dafni U, Bogaerts J, Kerst JM, Zielinski C, Piccart-Gebhart M, de Vries EG
Jaar : 2016
Journal : Ann Oncol
Volume : 27(11)
Pagina's : 2136-7

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.

Auteurs : Ignatiadis M, Zardavas D, Lemort M, Wilke C, Vanderbeeken MC, Dhondt V, de Azambuja E, Gombos A, Lebrun F, Dal Lago L, Bustin F, Maetens M, Ameye L, Veys I, Michiels S, Paesmans M, Larsimont D, Sotiriou C, Nogaret JM, Piccart-Gebhart M, Awada A
Jaar : 2016
Journal : PLoS One
Volume : 11(7)
Pagina's : e0154009